Anti-agalsidase antibodies Mass cytometry Antisynthétase Antiphospholipid syndrome Antibody responses AAV vectors Prognosis Auto-immunité Anti-MDA5 autoantibodies Inflammation Adjudication B-lymphocyte Middle Aged IBM Amyotrophy Autoimmunity Interferon Deep immune profiling Skeletal muscle Autoantibody Active Abnormal movement Acute Kidney Injury/epidemiology/etiology Pharmacology Cytokines Cancer Adolescence Interstitial lung disease Dermatomyositis Adeno-associated vector Anémie hémolytique AAV humoral immunity Fabry disease DM Antisynthetase syndrome Anticorps spécifique des myosites Immunotherapy Analyses multidimensionnelles B cell homeostasis Aldostérone Systems biology Myositis Adverse drug reactions Assisted communication devices Lysosomal storage diseases Anti-interleukin-6 Adeno-associated virus vector Sphingosine-1-phosphate Biomarkers Myocarditis Animals Immune checkpoint inhibitors AAV antibody Muscle Acid-alpha-glucosidase Male COVID-19 Female Inborn errors of metabolism Anti-drug antibodies Adeno-associated virus Biomarqueurs Autoimmune diseases Idiopathic inflammatory myopathies Multidisciplinarity AAV vector Aldosterone Dependovirus/genetics/immunology Aged Gene therapy Machine learning Arthritis Auto-antibodies Agalsidase Biomarker Amyotrophic lateral sclerosis Anti‐mitochondrial antibodies Cardio-oncology Antibodies Case reports Myopathy Humans Anti-synthetase syndrome IMNM Data integration Inclusion body myositis Anti-Mi2 Myositis and muscle disease Outcome measures AAV Autoantibodies Antisynthetase Polymyositis Auto‐antibodies Anti-IgE IgG Biopsy Inflammatory myopathy Bioelectrical impedance analysis Anticorps anti-agalsidase Adult